Home Page Overall Ranking ROE Ranking P/E Ranking Dividend Yield Capitalization Our eBook Our Book Contact










Isin US0718131099
Ticker BAX
Company BAXTER INTERNATIONAL
Currency $
Price
Aware Investor Index (AII) 7.9330
Recommendation BUY
P/E 14.85
ROE 21.17 %
Capitalization 27,872,730,000 $
Dividend Yield 2.50 %
P/S 2.80
AII Position 120
P/E Position 135
ROE Position 151
Capitalization Position 290
Dividend Yield Position 252
Sales 9,968,000,000 $
10-Year Average Earnings 1,877,000,000 $
Shares Outstanding 549,000,000
Equity 8,865,000,000 $
Dividend per Share 1.27 $
Industry Medical Equipment
Country United States
BAXTER INTERNATIONAL Investor Relations Web Site http://investor.baxter.com







Sales:

YEAR MONTH AMOUNT
2015 12 9,968,000,000.00 $
2014 12 10,719,000,000.00 $
2013 12 9,413,000,000.00 $
2012 12 14,190,000,000.00 $
2011 12 13,893,000,000.00 $
2010 12 12,843,000,000.00 $
2009 12 12,562,000,000.00 $
2008 12 12,348,000,000.00 $
2007 12 11,263,000,000.00 $
2006 12 10,378,000,000.00 $

Earnings:

YEAR MONTH AMOUNT
2015 12 968,000,000.00 $
2014 12 2,497,000,000.00 $
2013 12 2,012,000,000.00 $
2012 12 2,326,000,000.00 $
2011 12 2,224,000,000.00 $
2010 12 1,420,000,000.00 $
2009 12 2,205,000,000.00 $
2008 12 2,014,000,000.00 $
2007 12 1,707,000,000.00 $
2006 12 1,397,000,000.00 $

Equity:

YEAR MONTH AMOUNT
2015 12 8,865,000,000.00 $
2014 12 8,156,000,000.00 $
2013 12 8,486,000,000.00 $
2012 12 6,978,000,000.00 $
2011 12 6,828,000,000.00 $

Shares Outstanding:

YEAR MONTH AMOUNT
2015 12 549,000,000
2014 12 547,000,000
2013 12 549,000,000
2012 12 556,000,000
2011 12 573,000,000

 












Bloomberg News for BAXTER INTERNATIONAL:

Jan 18, 2017
The Post-Snowden Cyber Arms Hustle
exploits that allowed the government to silently hack mobile phones. —With reporting from Pauline Bax in Johannesburg and Gwen Ackerman in Jerusalem...
Jul 9, 2007
The Search for Angiogenesis Therapy
involves players across the health-care spectrum, including Genzyme (GENZ) and Baxter International (BAX) in search of gene-based therapies, and Boston Scientific (BSX) in the area of medical devices...
Sep 13, 2002
Buy Gannett
shares are at a premium valuation of 28 times S&P's 2003 EPS forecast. Baxter International (BAX ): Downgrades to 3 STARS (hold) from 4 STARS (accumulate) Analyst: Robert Gold ...
Jul 18, 2002
S&P Lowers Chip Equipment Stocks
their historical troughs, S&P continues to see some as over-valued. Baxter International (BAX ): Reiterates 4 STARS (accumulate) Analyst: Robert Gold Baxter maintains its...
Feb 5, 2007
Nature's Antidote To Nerve Gas
January, injecting 20 adult volunteers with butyrylcholinesterase, a protein derived from plasma (BAX). PharAthene of Annapolis, Md., is producing a recombinant version of the protein in the...
May 26, 2003
Electron Beams for Everyone
some 30 companies are studying AEB's prototypes, including 3M (MMM ) Baxter International (BAX ), and Sun Chemical. Painting may be one of the first uses to pan out because the electrons...
Mar 14, 2003
Trimming Estimate for Alcoa
cuts at largest customer Mar. 13 Company: Baxter International (BAX ) Year ending: Dec-03 Prior estimate: 2.20 New estimate: 1.90 Rationale:...
Sep 23, 2005
Goldman Leads in Finance Chief Pay: Graef Crystal
Allegheny Energy Jeffrey Serkes $14,171 563% Pixar Simon Bax $13,719 553% Station Casinos Inc. Glenn Christenson $6,228 426%...
Jun 6, 2005
Harry Kraemer: Baxter's Ex-CEO Goes Private
Harry Jansen Kraemer Jr. walked the walk. When Baxter International (BAX) was posting higher numbers year after year in the early 2000s, CEO Kraemer took his share of the credit. And when the medical-products...
Oct 23, 2000
It's The People, Stupid
(SQST), for instance, hired salespeople from distributors such as Baxter International Inc. (BAX) and VWR Scientific Products. Says Marlis Elliott, a purchasing manager at Cell Genesys Inc.: "The...


Google News for BAXTER INTERNATIONAL:

USA Commerce Daily - 18 hours ago
Buy/Sell Signals for Baxter International Inc. (BAX) and La Quinta ...
Shares of Baxter International Inc. (NYSE:BAX) are on a recovery track as they have regained 36.63% since bottoming out at $42.22 on Jun.
StreetInsider.com - 6 days ago
Goldman Sachs Starts Baxter International (BAX) at Conviction Buy
Get access to the best calls on Wall Street with StreetInsider.com's Ratings Insider Elite. Get your Free Trial here.
Sports Perspectives
Baxter International (BAX) Earns Media Impact Rating of 0.02
Baxter International logo Media coverage about Baxter International (NYSE:BAX) has trended somewhat positive on Sunday, according to ...
USA Commerce Daily
Baxter International (BAX) Q1 2017 Results - Earnings Call Transcript
Good morning, ladies and gentlemen, and welcome to Baxter International's First Quarter 2017 Earnings Conference Call. Your lines will ...
The Cerbat Gem
Baxter International (BAX) Q1 Earnings Beat, FY17 View Up
Baxter International Inc. BAX reported first-quarter 2017 adjusted earnings of 58 cents per share, which surpassed the Zacks Consensus ...
Sports Perspectives - 1 day ago
Baxter International Inc. (BAX) Has Just Revealed This From The ...
Baxter International Inc. (BAX) is now trading with a very clear set of technicals. Taken together they paint a very compelling picture of how ...
Herald KS
Baxter International Inc. (BAX) Makes Compelling Case Using Its ...
Baxter International Inc. (BAX) has created a compelling message for traders in the most recent trading. That message has grown stronger as ...
BangaloreWeekly
Traders Secrets on Baxter International Inc. (BAX), Sirius XM ...
Baxter International Inc. (NYSE:BAX) plunged -1.25% with the closing price of $56.86. The overall volume in the last trading session was 3.14 ...
The Cerbat Gem
South State (SSB) At $83.30 Forms Top; Baxter International (BAX)'s ...
South State Corporation (SSB) formed multiple top with $85.80 target or 3.00% above today's $83.30 share price. South State Corporation ...
Seeking Alpha - 26 Apr 2017
A Look at the valuation of Baxter International Inc. (NYSE:BAX)
Baxter International Inc. (NYSE:BAX) has an ERP5 rank of 7014. The ERP5 Rank is an investment tool that analysts use to discover ...


Back